Publication:

A prospective, open label, randomized study of efficacy of vitamin A as an add on therapy in the clinical outcome of tuberculosis patients

Background Tuberculosis is the most prevalent infectious disease in the world. India accounts for nearly one fifth of global incidence of tuberculosis. If untreated the disease may be fatal within five years in 50-65 percent of cases. Many decades of research have shown that severe oxidative stress plays a significant role in tuberculosis patients. Moreover, the malnutrition which is commonly present in patient with tuberculosis can add to the impaired anti oxidant capacity. The present study was to investigate the effect of supplementation of vitamin A with standard treatment on the health status of newly diagnosed sputum positive pulmonary tuberculosis patients.

Methods Phase III, prospective, open, two arm parallel group, outpatient, randomized, active controlled study. Centre of the study was Tuberculosis clinic, Department of Internal medicine, Stanley Medical College Chennai.Duration of the study was for active drug therapy - 2 months, for follow up period - 4 months and for total period - 6 months.

Results In our study it was evident that there was a statistically significant improvement in the Karnofsky’s score, body mass index, mid upper arm circumference in the in the vitamin A supplementation group when compared to the control group at the end of 2 months and 6 months. And also, a statistically significant decrease in C.R.P. levels and E.S.R levels were also observed.

Conclusions This study shows that vitamin A as an add on therapy with regular anti-tuberculosis treatment improves the quality of life and decreases the disease activity in pulmonary tuberculosis patients to a greater extent than with routine standard drug therapy alone.